No abstract available
Publication types
-
Guideline
-
Practice Guideline
MeSH terms
-
Fibrinolytic Agents / therapeutic use*
-
Heparin / administration & dosage
-
Heparin / therapeutic use
-
Humans
-
Infusions, Intra-Arterial
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / therapeutic use
-
Stroke / drug therapy*
-
Thrombolytic Therapy* / adverse effects
-
Thrombolytic Therapy* / standards
-
Time Factors
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
-
Urokinase-Type Plasminogen Activator / administration & dosage
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Fibrinolytic Agents
-
Recombinant Proteins
-
Heparin
-
Tissue Plasminogen Activator
-
Urokinase-Type Plasminogen Activator
-
saruplase